Related Experiment Video
Updated: Jan 18, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Association Between Free Triiodothyronine and Diabetic Peripheral Neuropathy in Euthyroid Patients With Type 2
Bing'er Xu1, Xinyu Yang1, Yu Ma2
1Department of Endocrinology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Objective:
To explore the relationship between free triiodothyronine (FT3) and diabetic peripheral neuropathy (DPN) in euthyroid patients with type 2 diabetes mellitus.
Methods:
We enrolled 1422 hospitalized patients with type 2 diabetes from Zhongshan Hospital, Fudan University. All participants underwent electromyographic examinations, including nerve conduction velocity (NCV), distal motor and sensor latency (DML and DSL), sensory nerve action potential (SNAP) amplitude, and compound muscle action potential (CMAP) amplitude.
Results:
A total of 519 (36.5%) patients with type 2 diabetes could be diagnosed as DPN according to their clinical symptoms and results of electromyography. Compared with those without DPN, the patients with DPN had a longer duration of diabetes, poorer blood glucose control, and lower BMI levels, accompanied with higher proportions of diabetic retinopathy, diabetic nephropathy, and cardiovascular disease (all P < .05). Serum FT3 level were significantly lower in patients with DPN than those without DPN (4.08 ± 0.64 vs 4.39 ± 0.63 pmol/L, P < .001), and FT3 was inversely correlated with the nerve DML and DSL, and positively correlated with the CMAP, SNAP, and NCV of all nerves we measured in the patients with DPN (all P < .05). The inverse correlation between serum FT3 and risk of DPN remained significant after multivariate adjustment for potential confounders (P < .05). A Mendelian randomization analysis also indicated a causal effect of serum FT3 on the risk of DPN.
Conclusion:
Low FT3 is a risk factor of DPN among euthyroid patients with type 2 diabetes.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

